• Username (E-mail)
  • Password
Dow 19,827 -0.3%  EStoxx50 3,285 -0.3%  Nikkei 18,814 -1.5%  EUR 1.0708 0.0% 
Nasdaq 5,539 -0.6%  FTSE100 7,220 -1.5%  Yen 112.7080 0.0%  Oil 55.5 -0.4% 
S&P500 2,268 -0.3%  DAX 11,540 -0.1%  GBP 1.2401 0.0%  Gold 1,216 0.0% 

Vertex Pharmaceuticals share [Symbol: VRTX / ISIN: US92532F1003]

12/14/2012 02:41:05 AM
12/14/2012 02:41:05 AM UTC-0500

Vertex Pharmaceuticals Inc. Sell

The analysts of Goldman Sachs Group Inc. have rated Vertex Pharmaceuticals with a Sell rating. The price target was set to 38.00 $. At a current price of the Vertex Pharmaceuticals stock of 81.55 $ this means a downside potential of -53.40%.
Summary: Vertex Pharmaceuticals Inc. Sell
Company:
Vertex Pharmaceuticals Inc.
Analyst:
Goldman Sachs Group Inc.
Price Target:
38.00 $
Current Rating:
Sell
Price*:
41.80 $
Distance to Target Price*:
-9.09%
Previous Rating:
reiterated
Latest Price:
81.55 $
Distance Price Target:
-53.40%
Analyst Name::
Terence Flynn
P/E Ratio*:
-

Analyst Opinions for Vertex Pharmaceuticals Inc.

More Analyst Opinions
  • All
  • Buy
  • Hold
  • Sell
12/14/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
12/05/12
Vertex Pharmaceuticals RBC Capital Markets
11/13/12
Vertex Pharmaceuticals Credit Suisse Group
11/05/12
Vertex Pharmaceuticals Goldman Sachs Group Inc.
11/02/12
Vertex Pharmaceuticals UBS AG

Add or Edit Instrument

Related Stocks

Latest Analyst Opinions
01/16/17 HUGO BOSS DZ BANK
01/16/17 Beiersdorf Macquarie Research
01/16/17 JCDecaux Citigroup Corp.
01/16/17 Infineon Technologies Credit Suisse Group
01/16/17 RWE Morgan Stanley
01/16/17 innogy Morgan Stanley
01/16/17 Swiss Re Credit Suisse Group
01/16/17 Enel Morgan Stanley
01/16/17 Hannover Rueck Credit Suisse Group
01/16/17 Münchener Rückversicherungs-Gesellschaft Credit Suisse Group
01/16/17 JCDecaux BNP PARIBAS
01/16/17 EON Morgan Stanley
01/16/17 Deutsche Telekom BNP PARIBAS
01/16/17 Groupe Danone UBS AG
01/16/17 Unilever UBS AG
01/16/17 STMicroelectronics JP Morgan Chase & Co.
01/16/17 Reckitt Benckiser Group UBS AG
01/16/17 Nestle SA UBS AG
01/16/17 Zalando JP Morgan Chase & Co.
01/16/17 Talanx Credit Suisse Group
01/16/17 Zurich Insurance Group Credit Suisse Group
01/16/17 Allianz Credit Suisse Group
01/16/17 AXA Credit Suisse Group
01/16/17 HUGO BOSS Commerzbank AG
01/16/17 Philips Lighting Kepler Cheuvreux
01/16/17 Drägerwerk vz Hauck & Aufhäuser Privatbankiers KGaA
01/16/17 ING Group Société Générale Group S.A. (SG)
01/16/17 Air Liquide Société Générale Group S.A. (SG)
01/16/17 HUGO BOSS Deutsche Bank AG
01/16/17 LVMH Moet Hennessy Louis Vuitton Deutsche Bank AG
01/16/17 Kering Deutsche Bank AG
01/16/17 Lloyds Banking Group Deutsche Bank AG
01/16/17 Software Deutsche Bank AG
01/16/17 HeidelbergCement Société Générale Group S.A. (SG)
01/16/17 Drägerwerk vz Norddeutsche Landesbank (Nord/LB)
01/16/17 Essilor International Kepler Cheuvreux
01/16/17 Hapag-Lloyd Aktiengesellschaft Kepler Cheuvreux
01/16/17 Ahold Delhaize Kepler Cheuvreux
01/16/17 METRO Kepler Cheuvreux
01/16/17 Allianz Deutsche Bank AG
01/16/17 Imperial Brands Jefferies & Company Inc.
01/16/17 British American Tobacco Jefferies & Company Inc.
01/16/17 GlaxoSmithKline Jefferies & Company Inc.
01/16/17 Drägerwerk vz Independent Research GmbH
01/16/17 FUCHS PETROLUB Independent Research GmbH
01/16/17 Beiersdorf UBS AG
01/16/17 Henkel vz UBS AG
01/16/17 LOréal UBS AG
01/16/17 Hannover Rueck Oddo Seydler Bank AG
01/16/17 HUGO BOSS Hauck & Aufhäuser Privatbankiers KGaA